Oral contraception. A review of reported physiological and pathological effects.
D000328:Adult; D000818:Animals; D002273:Carcinogens / Q000494:pharmacology; D002784:Cholesterol / Q000009:adverse effects; D003271:Contraceptive Agents, Female / Q000009:adverse effects*; D003278:Contraceptives, Oral, Hormonal / Q000009:adverse effects; D003327:Coronary Disease / Q000139:chemically induced; D004967:Estrogens / Q000009:adverse effects; D005260:Female; D005298:Fertility / Q000187:drug effects; D005951:Glucose Tolerance Test; D006760:Hospitalization; D006801:Humans; D006973:Hypertension / Q000139:chemically induced; D002542:Intracranial Embolism and Thrombosis / Q000139:chemically induced / Q000401:mortality; D008074:Lipoproteins / Q000009:adverse effects; D008111:Liver Function Tests; D051379:Mice; D009374:Neoplasms, Experimental; D011247:Pregnancy; D011374:Progesterone / Q000009:adverse effects; D011655:Pulmonary Embolism / Q000139:chemically induced / Q000401:mortality; D051381:Rats; D013923:Thromboembolism / Q000139:chemically induced; D013924:Thrombophlebitis / Q000139:chemically induced; D014280:Triglycerides / Q000009:adverse effects
D002273:Carcinogens; D003271:Contraceptive Agents, Female; D003278:Contraceptives, Oral, Hormonal; D004967:Estrogens; D008074:Lipoproteins; D014280:Triglycerides; D011374:Progesterone; D002784:Cholesterol